Is Renal Function Associated with Early Age-Related Macular Degeneration?
暂无分享,去创建一个
R. Klein | T. Wong | Jie-Jin Wang | B. Klein | R. Guymer | M. Shlipak | M. Cotch | E. Chong | T. Wong | T. Wong | R. Klein
[1] Josef Coresh,et al. Cystatin C versus creatinine in determining risk based on kidney function. , 2013, The New England journal of medicine.
[2] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[3] Josef Coresh,et al. Chronic kidney disease , 2012, The Lancet.
[4] J. Moon,et al. Chronic Kidney Disease, Early Age-related Macular Degeneration, and Peripheral Retinal Drusen , 2011, Ophthalmic epidemiology.
[5] Robyn H Guymer,et al. Identification of urinary biomarkers for age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[6] R. Klein,et al. Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. , 2011, Ophthalmology.
[7] R. Klein,et al. Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2009, Archives of ophthalmology.
[8] L. Smeeth,et al. Associations Between Chronic Kidney Disease and Age-Related Macular Degeneration , 2009, Ophthalmic epidemiology.
[9] P. Mitchell,et al. CKD increases the risk of age-related macular degeneration. , 2008, Journal of the American Society of Nephrology : JASN.
[10] J. J. Wang,et al. Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study , 2008, Genes and Immunity.
[11] R. Klein,et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.
[12] 上村 治. 知っておきたい用語の解説 Chronic Kidney Disease(CKD) , 2007 .
[13] P. Mitchell,et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2007, Ophthalmology.
[14] E. Im,et al. The role of cathepsins in ocular physiology and pathology. , 2007, Experimental eye research.
[15] M. Shlipak. Cystatin C as a marker of glomerular filtration rate in chronic kidney disease: influence of body composition , 2007, Nature Clinical Practice Nephrology.
[16] B. Kestenbaum,et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.
[17] R. Klein,et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.
[18] A. Christensson,et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. , 2005, Clinical chemistry.
[19] T. Mathew. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement , 2005, The Medical journal of Australia.
[20] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] E. Im,et al. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.
[22] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[23] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[24] L. Fried,et al. Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults , 2005, Annals of Internal Medicine.
[25] T. Greene,et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[26] R. Klein,et al. Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. , 2004, Archives of ophthalmology.
[27] B. Munoz,et al. Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. , 2004, Archives of ophthalmology.
[28] J. H. Jansen,et al. The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. , 2002, The American journal of pathology.
[29] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[30] V. Dharnidharka,et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[32] P. Mitchell,et al. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. , 1996, Ophthalmology.
[33] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[34] R. Gokal,et al. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. , 1989, The British journal of ophthalmology.
[35] N. McKechnie,et al. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. , 1989, The British journal of ophthalmology.
[36] R. Sperduto,et al. Systemic hypertension and age-related maculopathy in the Framingham Study. , 1986, Archives of ophthalmology.
[37] G. Filler,et al. Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.
[38] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[39] A. Barrett. The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.